A detailed history of Franklin Resources Inc transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 1,024,991 shares of PLRX stock, worth $12.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,024,991
Previous 1,536,850 33.31%
Holding current value
$12.9 Million
Previous $22.9 Million 51.88%
% of portfolio
0.0%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$10.58 - $15.61 $5.42 Million - $7.99 Million
-511,859 Reduced 33.31%
1,024,991 $11 Million
Q1 2024

May 13, 2024

SELL
$14.14 - $19.59 $604,089 - $836,923
-42,722 Reduced 2.7%
1,536,850 $22.9 Million
Q4 2023

Feb 09, 2024

BUY
$12.85 - $19.15 $798,923 - $1.19 Million
62,173 Added 4.1%
1,579,572 $28.6 Million
Q3 2023

Nov 13, 2023

BUY
$14.58 - $20.15 $248,953 - $344,061
17,075 Added 1.14%
1,517,399 $26.3 Million
Q2 2023

Aug 11, 2023

BUY
$18.12 - $30.56 $201,548 - $339,918
11,123 Added 0.75%
1,500,324 $27.2 Million
Q1 2023

May 12, 2023

SELL
$18.73 - $36.26 $4,551 - $8,811
-243 Reduced 0.02%
1,489,201 $39.6 Million
Q4 2022

Feb 10, 2023

SELL
$17.0 - $25.43 $46,563 - $69,652
-2,739 Reduced 0.18%
1,489,444 $28.8 Million
Q3 2022

Nov 14, 2022

BUY
$7.67 - $24.23 $8.11 Million - $25.6 Million
1,057,440 Added 243.23%
1,492,183 $31.2 Million
Q2 2022

Aug 11, 2022

BUY
$4.11 - $8.75 $2,170 - $4,620
528 Added 0.12%
434,743 $3.48 Million
Q4 2021

Feb 11, 2022

BUY
$12.27 - $18.26 $462,652 - $688,511
37,706 Added 9.51%
434,215 $5.86 Million
Q2 2021

Aug 13, 2021

BUY
$28.05 - $37.69 $1.3 Million - $1.75 Million
46,500 Added 13.29%
396,509 $11.5 Million
Q4 2020

Feb 10, 2021

BUY
$19.89 - $32.99 $179 - $296
9 Added 0.0%
350,009 $7.95 Million
Q2 2020

Aug 13, 2020

BUY
$21.3 - $35.26 $7.46 Million - $12.3 Million
350,000 New
350,000 $8.92 Million

Others Institutions Holding PLRX

About PLIANT THERAPEUTICS, INC.


  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $614M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.